Rossella Graffeo

1.1k total citations
31 papers, 549 citations indexed

About

Rossella Graffeo is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Rossella Graffeo has authored 31 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Genetics and 12 papers in Cancer Research. Recurrent topics in Rossella Graffeo's work include BRCA gene mutations in cancer (12 papers), Cancer Treatment and Pharmacology (6 papers) and Breast Cancer Treatment Studies (6 papers). Rossella Graffeo is often cited by papers focused on BRCA gene mutations in cancer (12 papers), Cancer Treatment and Pharmacology (6 papers) and Breast Cancer Treatment Studies (6 papers). Rossella Graffeo collaborates with scholars based in Switzerland, Italy and United States. Rossella Graffeo's co-authors include Aron Goldhirsch, Olivia Pagani, Giovanni Martinelli, Franco Nolè, Beat Thürlimann, Diana Crivellari, Cristiana Sessa, Markus Borner, Dagmar Hess and Jean Bauer and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Rossella Graffeo

27 papers receiving 539 citations

Peers

Countries citing papers authored by Rossella Graffeo

Since Specialization

Citations

This map shows the geographic impact of Rossella Graffeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rossella Graffeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rossella Graffeo more than expected).

Fields of papers citing papers by Rossella Graffeo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rossella Graffeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rossella Graffeo. The network helps show where Rossella Graffeo may publish in the future.

Co-authorship network of co-authors of Rossella Graffeo

This figure shows the co-authorship network connecting the top 25 collaborators of Rossella Graffeo. A scholar is included among the top collaborators of Rossella Graffeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rossella Graffeo. Rossella Graffeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Albumin-To-Alkaline Phosphatase Ratio as a New Early Predictive Marker of Axillary Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Pilot Study 2024 ·Medicina ·(unknown), Yves Harder, Lorenzo Rossi, (unknown), Simone Schiaffino, Arianna Calcinotto, (unknown), Rossella Graffeo, (unknown), Claudia Canonica, Marco Cuzzocrea, Ammad Ahmad Farooqi, (unknown), (unknown), Nickolas Peradze, Andrea Papadia, Alberto Pagnamenta, Maria Luisa Gasparri	1
2	Beyond PARP Inhibitors in Advanced Breast Cancer Patients with Germline BRCA1/2 Mutations: Focus on CDK4/6-Inhibitors and Data Review on Other Biological Therapies 2023 ·Cancers ·(unknown), Lorenzo Rossi, Rosaria Condorelli, (unknown), Fabio Conforti, Antonella Palazzo, Rossella Graffeo	4
3	Germline TP53 pathogenic variants and breast cancer: A narrative review 2023 ·Cancer Treatment Reviews ·Eva Blondeaux, Luca Arecco, Kevin Punie, Rossella Graffeo, Angela Toss, Carmine De Angelis, (unknown), Giulia Buzzatti, Sabine C. Linn, Peter Dubsky, (unknown), Ann H. Partridge, Judith Balmañà, Shani Paluch–Shimon, Matteo Lambertini	25
4	478P Germline BRCA1/2 pathogenetic variants (gBRCA1/2 PV) affect outcome of hormone (HR)-positive HER2-negative metastatic breast cancer (MBC) patients (pts) treated with cyclin-dependent kinase 4/6 inhibitor (CDK 4/6i) plus endocrine therapy (ET): The BREAK study 2023 ·Annals of Oncology ·Antonella Palazzo, Angela Toss, Rossella Graffeo, Andrea Fontana, Matteo Lambertini, (unknown), Marta Perachino, (unknown), Nadia Bianco, Patrizia Vici, Laura De Marchis, Nicoletta Staropoli, L. Rinaldi, Antonella Lai, Gian Paolo Spinelli, E. Di Monte, Francesco Giotta, Alessandra Gennari, Laura Cortesi, Emilio Bria	6
5	Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D 2022 ·The Breast ·Rossella Graffeo, Huma Q. Rana, Fabio Conforti, Bernardo Bonanni, Maria João Cardoso, Shani Paluch–Shimon, Olivia Pagani, Aron Goldhirsch, Ann H. Partridge, Matteo Lambertini, Judy E. Garber	41
6	Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort 2022 ·Cancers ·(unknown), Chang Ming, (unknown), Nicole Bürki, Maria Caiata Zufferey, Tobias E. Erlanger, Rossella Graffeo, Karl Heinimann, Viola Heinzelmann‐Schwarz, Christian Monnerat, Nicole Probst‐Hensch, Manuela Rabaglio, Ursina Zürrer‐Härdi, Pierre O. Chappuis, Maria C. Katapodi	14
7	Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort 2022 ·Journal of Personalized Medicine ·(unknown), Chang Ming, (unknown), Günther Fink, (unknown), Nicole Bürki, Rossella Graffeo, Karl Heinimann, Maria Caiata Zufferey, Christian Monnerat, Manuela Rabaglio, Ursina Zürrer‐Härdi, Pierre O. Chappuis, Maria C. Katapodi	9
8	Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer 2021 ·Swiss Medical Weekly ·(unknown), Sheila Unger, Silvia Azzarello‐Burri, Pierre O. Chappuis, Rossella Graffeo, Gabriella Pichert, Benno Röthlisberger, (unknown), (unknown)	5
9	Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis 2021 ·The Breast ·Maria Luisa Gasparri, Rosa Di Micco, Veronica Zuber, Katayoun Taghavi, Giampaolo Bianchini, (unknown), Francesco Meani, Rossella Graffeo, Massimo Candiani, Michael D. Mueller, Andrea Papadia, Oreste Gentilini	10
10	Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence 2019 ·Breast Cancer Research ·Fabio Conforti, Laura Pala, Eleonora Pagan, Giuseppe Viale, Vincenzo Bagnardi, G. Peruzzotti, Tommaso De Pas, Nadia Bianco, Rossella Graffeo, Elena Guerini‐Rocco, Andrea Vingiani, Richard D. Gelber, Alan S. Coates, Marco Colleoni, Aron Goldhirsch	13
11	Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol 2017 ·JMIR Research Protocols ·Maria C. Katapodi, Valeria Viassolo, Maria Caiata Zufferey, Christos Nikolaidis, (unknown), (unknown), Rossella Graffeo, Henrik Csaba Horváth, Christian Kurzeder, Manuela Rabaglio, (unknown), Corinne Urech, Tobias E. Erlanger, Nicole Probst‐Hensch, Karl Heinimann, Viola Heinzelmann‐Schwarz, Olivia Pagani, Pierre O. Chappuis	23
12	Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care 2016 ·Breast Cancer Research and Treatment ·Rossella Graffeo, Luca Livraghi, Olivia Pagani, Aron Goldhirsch, Ann H. Partridge, Judy E. Garber	45
13	Outcome of Immediate Breast Reconstruction in Patients With Nonendocrine-Responsive Breast Cancer: A Monoinstitutional Case-Control Study 2015 ·Clinical Breast Cancer ·Gaetano Aurilio, Vincenzo Bagnardi, Franco Nolè, Giancarlo Pruneri, Rossella Graffeo, Jean‐Yves Petit, Daniela Cullurà, Stefano Martella, Marzia Locatelli, Marco Iera, Piercarlo Rey, Giuseppe Curigliano, Nicole Rotmensz, Elisabetta Munzone, Aron Goldhirsch	13
14	Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case series 2014 ·International Journal of Clinical Oncology ·Gaetano Aurilio, Rossella Graffeo, Vincenzo Bagnardi, Franco Nolè, Laura Adamoli, Olivia Pagani, Elisa Gallerani, (unknown), Giancarlo Pruneri, Aron Goldhirsch	1
15	Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer? 2014 ·PubMed ·Gaetano Aurilio, Vincenzo Bagnardi, Rossella Graffeo, Franco Nolè, Jean‐Yves Petit, Marzia Locatelli, Stefano Martella, Marco Iera, Piercarlo Rey, Giuseppe Curigliano, Nicole Rotmensz, Elisabetta Munzone, Aron Goldhirsch	15
16	Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer 2005 ·Annals of Oncology ·Olivia Pagani, Cristiana Sessa, Franco Nolè, Elisabetta Munzone, Diana Crivellari, Davide Lombardi, Beat Thürlimann, Dagmar Hess, Rossella Graffeo, Marco Ruggeri, Sauro Longhi, Aron Goldhirsch	3
17	High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel 2001 ·Annals of Oncology ·Diana Crivellari, Olivia Pagani, Andrea Veronesi, Davide Lombardi, Franco Nolè, Beat Thürlimann, Dagmar Hess, Markus Borner, Jean Bauer, Giovanni Martinelli, Rossella Graffeo, Cristiana Sessa, Aron Goldhirsch	116
18	Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I–II study 2000 ·Annals of Oncology ·Olivia Pagani, Cristiana Sessa, Franco Nolè, Diana Crivellari, Davide Lombardi, Beat Thürlimann, Dagmar Hess, Markus Borner, Jean Bauer, Giovanni Martinelli, Rossella Graffeo, Massimo Zucchetti, Maurizio D’Incalci, Aron Goldhirsch	46
19	Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer 1999 ·Annals of Oncology ·Olivia Pagani, Cristiana Sessa, Giovanni Martinelli, Diana Crivellari, Angela Buonadonna, Beat Thürlimann, Dagmar Hess, Markus Borner, Jean Bauer, (unknown), (unknown), Rossella Graffeo, A. Riva, Aron Goldhirsch	39
20	Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen. 1998 ·Journal of Clinical Oncology ·Marco Colleoni, Giovanni Martinelli, (unknown), Claudio Marone, Augusto Gallino, Margherita Fontana, Rossella Graffeo, (unknown), Tommaso De Pas, (unknown), (unknown), Aron Goldhirsch	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact